OBJECTIVE: To investigate cytokeratin 19 (CK19) expression in oral squamous cell carcinoma (OSCC) tissue as well as its correlation with pathologic differentiation grade and prognosis. STUDY DESIGN: Cancerous and distant tissues from 33 primary OSCC patients were collected during surgery. Each sample was divided into 2 parts, one for CK19 protein detection using immunohistochemistry, and the other for CK19 mRNA-level detection of relative quantification using fluorescent real-time reverse transcriptase polymerase chain reaction (RT-PCR). RESULTS: The CK19 positive rate in cancerous tissue was 90.9% (30 out of 33) detected using immunohistochemistry, which was significantly higher than that in distant tissue (15.2%, 5 out of 33) by chi-square test (P < .001). The CK19 positive score in cancerous tissue was also significantly higher than that in the corresponding distant tissue by paired samples t test (P < .001). Patients with positive CK19 expression in distant tissue had higher tumor recurrence rate (P = .008) and lower survival rate (P = .015) than those with negative CK19 expression in distant tissue. Using fluorescent real-time RT-PCR, CK19 mRNA level in cancerous tissue was 2.21-fold higher than that in distant tissue (P = .020). The CK19 expression correlated significantly with pathologic differentiation grade, which was detected not only using immunohistochemistry (P = .002) but also using fluorescent real-time RT-PCR (P = .025), poorer differentiated indicating higher CK19 positive score and CK19 mRNA level. CONCLUSIONS: Increased CK19 protein expression and gene transcription in OSCC tissue correlate significantly with pathologic differentiation grade. Positive CK19 expression in distant tissue suggests a higher tumor recurrence rate and a lower survival rate.
OBJECTIVE: To investigate cytokeratin 19 (CK19) expression in oral squamous cell carcinoma (OSCC) tissue as well as its correlation with pathologic differentiation grade and prognosis. STUDY DESIGN:Cancerous and distant tissues from 33 primary OSCC patients were collected during surgery. Each sample was divided into 2 parts, one for CK19 protein detection using immunohistochemistry, and the other for CK19 mRNA-level detection of relative quantification using fluorescent real-time reverse transcriptase polymerase chain reaction (RT-PCR). RESULTS: The CK19 positive rate in cancerous tissue was 90.9% (30 out of 33) detected using immunohistochemistry, which was significantly higher than that in distant tissue (15.2%, 5 out of 33) by chi-square test (P < .001). The CK19 positive score in cancerous tissue was also significantly higher than that in the corresponding distant tissue by paired samples t test (P < .001). Patients with positive CK19 expression in distant tissue had higher tumor recurrence rate (P = .008) and lower survival rate (P = .015) than those with negative CK19 expression in distant tissue. Using fluorescent real-time RT-PCR, CK19 mRNA level in cancerous tissue was 2.21-fold higher than that in distant tissue (P = .020). The CK19 expression correlated significantly with pathologic differentiation grade, which was detected not only using immunohistochemistry (P = .002) but also using fluorescent real-time RT-PCR (P = .025), poorer differentiated indicating higher CK19 positive score and CK19 mRNA level. CONCLUSIONS: Increased CK19 protein expression and gene transcription in OSCC tissue correlate significantly with pathologic differentiation grade. Positive CK19 expression in distant tissue suggests a higher tumor recurrence rate and a lower survival rate.
Authors: Ebbing P de Jong; Hongwei Xie; Getiria Onsongo; Matthew D Stone; Xiao-Bing Chen; Joel A Kooren; Eric W Refsland; Robert J Griffin; Frank G Ondrey; Baolin Wu; Chap T Le; Nelson L Rhodus; John V Carlis; Timothy J Griffin Journal: PLoS One Date: 2010-06-17 Impact factor: 3.240
Authors: Ali Yousif Babiker; Arshad H Rahmani; Mohamed S Abdalaziz; Aqel Albutti; Salah M Aly; Hussain Gadelkareem Ahmed Journal: Int J Clin Exp Med Date: 2014-06-15
Authors: Takeshi Toyoshima; Eleftherios Vairaktaris; Emeka Nkenke; Karl Andreas Schlegel; Friedrich Wilhelm Neukam; Jutta Ries Journal: J Cancer Res Clin Oncol Date: 2007-09-04 Impact factor: 4.553
Authors: Maria F S D Rodrigues; Camila de Oliveira Rodini; Flávia C de Aquino Xavier; Katiúcia B Paiva; Patrícia Severino; Raquel A Moyses; Rossana M López; Rafael DeCicco; Lília A Rocha; Marcos B Carvalho; Eloiza H Tajara; Fabio D Nunes Journal: Medicine (Baltimore) Date: 2014-12 Impact factor: 1.889